Type 2 Diabetes Trial, Recruiting NCT07237685 Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07237685
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old
  • People who have previously had a CT scan of the heart's arteries (called a CCTA scan) to check for heart disease
  • People who have been diagnosed with Type 2 Diabetes and are currently taking medication to lower their blood sugar
  • People whose CCTA scan images were clear enough to be assessed (at least two out of three blood vessels need to be clearly visible)
  • People whose CCTA scan was performed no less than 2 years and no more than 5 years before joining the trial

Who may not be able to join:

  • People who are unable to provide written consent to participate
  • People who have an unstable medical condition at the time of the trial
  • People with severely reduced kidney function (a measure called eGFR at or below 30 mL/min/1.73m²), or who have a known allergy or medical reason to avoid the dye used in CT scans
  • People with any other medical condition or treatment that the trial doctor believes could interfere with the trial's results or process
  • People who are unable or unwilling to follow the trial's requirements, or who the trial doctor considers unsuitable for the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31205662402

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Registry
ClinicalTrials.gov
Start date
6 June 2025
Est. completion
1 October 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

progression of total coronary plaque volume (mm3)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov